Research "AMBS" - Amarantus Bioscience - MANF is the real deal.
Twitter: @AmarantusBio .... 8,543 followers
MANF has the potential to treat diabetes, Parkinson's, Alzheimer's, Retinitis Pigmentosa, and numerous other diseases. Bargain at under a dime.
Current market cap of about $29M. It's substantially undervalued.
Read today's Yahoo news. Planning to up-list and no additional funding required.
Becton Dickinson deal expected at any time. Will triple the share price.